| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/02/2023 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 10k | $2.08 | $20.8k | | 06/02/2023 |
| 10/17/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 10k | $2.08 | $20.8k | | 10/17/2022 |
| 05/03/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 20k | $2.08 | $41.6k | | 05/03/2022 |
| 03/01/2022 | Kymera Therapeutics, Inc. | | Grant | Common Stock | 13.3k | $0.00 | $0 | | 03/01/2022 |
| 03/01/2022 | Kymera Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 80k | $38.53 | $3.1M | | 03/01/2022 |
| 01/14/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 10k | $2.08 | $20.8k | | 01/14/2022 |
| 01/12/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 6.4k | $51.21 | $329.1k | | 01/12/2022 |
| 01/12/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 7.2k | $52.13 | $372.8k | | 01/12/2022 |
| 01/12/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 1.4k | $53.27 | $75.7k | | 01/12/2022 |
| 01/12/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 15k | $2.08 | $31.2k | | 01/12/2022 |
| 12/03/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 7.7k | $53.31 | $411.2k | | 12/03/2021 |
| 12/03/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 2k | $54.32 | $107.9k | | 12/03/2021 |
| 12/03/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 300 | $55.07 | $16.5k | | 12/03/2021 |
| 12/03/2021 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 10k | $2.08 | $20.8k | | 12/03/2021 |
| 11/23/2021 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 10k | $2.08 | $20.8k | | 11/23/2021 |
| 09/03/2021 | Kymera Therapeutics, Inc. | | Exercise | Common Stock | 10k | $2.08 | $20.8k | | 09/03/2021 |
| 09/03/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 8.5k | $60.05 | $510.4k | | 09/03/2021 |
| 09/03/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 1.5k | $60.50 | $90.7k | | 09/03/2021 |
| 09/03/2021 | Kymera Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 10k | $2.08 | $20.8k | | 09/03/2021 |
| 06/03/2021 | Kymera Therapeutics, Inc. | | Exercise | Common Stock | 10k | $2.08 | $20.8k | | 06/03/2021 |
| 06/03/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 5.5k | $46.66 | $256.9k | | 06/03/2021 |
| 06/03/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 4.5k | $47.13 | $211.8k | | 06/03/2021 |
| 06/03/2021 | Kymera Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 10k | $2.08 | $20.8k | | 06/03/2021 |
| 04/13/2021 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 7k | $2.08 | $14.6k | | 04/13/2021 |
| 03/15/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 8.2k | $60.17 | $493.1k | | 03/11/2021 |
| 03/15/2021 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 8.2k | $2.08 | $17k | | 03/11/2021 |
| 03/11/2021 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 1.8k | $2.08 | $3.8k | | 03/11/2021 |
| 03/11/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 1.8k | $60.07 | $108.4k | | 03/11/2021 |
| 03/08/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 7.7k | $50.46 | $388.5k | | 03/08/2021 |
| 03/08/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 2.3k | $51.28 | $117.9k | | 03/08/2021 |
| 03/08/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 1 | $52.15 | $52.2 | | 03/08/2021 |
| 03/08/2021 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 10k | $2.08 | $20.8k | | 03/08/2021 |
| 03/03/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 6.9k | $44.12 | $303.6k | | 03/03/2021 |
| 03/03/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 12k | $45.07 | $541.7k | | 03/03/2021 |
| 03/03/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 1.1k | $45.75 | $50.3k | | 03/03/2021 |
|